3Bowers B, Kom ED. The fine structure of acanthamoeba castellanii. J Cell Biology, 1968:95-111.
4Ludwig IH, Meisler DM, Rutherford I, et al. Susceptibility of acanthamoeba to soft content lensdisinfection systems. Invest Ophthalmol Vis Sci, 1986,27:626-628.
5Brandt FH, Ware DA, Visvesvara GS. Viability of acanthamoeba cysts in ophthalmic solutions. Appl Environ Microbiol, 1989,55 : 1144-1146.
6Silvany RE, Dougherty JM, McCulley JP, et al. The effect of currently available contact lens disinfection systems on acanthamoeba castellanii and acanthamoeba polyphaga. Ophthalmology, 1990, 97: 286-290.
7Hay J, Kirkness CM, Seal DV, et al. Drug resistance and acanthamoeba keratitis: the quest for alterative antiprotozoal chemotherapy. Eye, 1994,8:555-563.
8Seel DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for acanth-amoeba keratitis. Lancet, 1995, 345:136.
10Lee JE, Oum BS, Choi HY, et al. Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea, 2007, 26 : 736-741.
